Simple summary Stereotactic body radiotherapy (SBRT) of 35–36.25 Gy in five fractions with
the CyberKnife System yields excellent control with low toxicity in low–intermediate-risk …

Purpose Several definitive treatment options are available for prostate cancer, but
geographic access to those options is not uniform. We created maps illustrating provider …

Abstract Purpose Adaptive Stereotactic Body Radiotherapy (SBRT) of prostate cancer (PC)
by online 1.5 T MRi-guidance prolongs session-time, due to contouring and planning tasks …

Background Extreme hypofractionation requires tight planning margins, high dose gradients,
and strict adherence to planning criteria in terms of patient positioning and organ motion …

Purpose Changes in fraction size of external beam radiation therapy exert nonlinear effects
on subsequent toxicity. Commonly described by the linear-quadratic model, fraction size …

Purpose To compare the biochemical control rates (BCRs), late gastrointestinal (GI) and
genitourinary (GU) toxicities in patients with low-and intermediate risk prostate cancer (PCa) …

Purpose Stereotactic body radiotherapy (SBRT) is an emerging treatment option for
localized prostate cancer. There is increasing interest to reduce the number of fractions for …

In the past decade, stereotactic body radiation therapy (SBRT) has emerged as a valid
treatment option for patients with localized prostate cancer. Despite the promising results of …

Prostate cancer is the most commonly diagnosed cancer among men around the world.
Radiotherapy is a standard of care treatment option for men with localized prostate cancer …

Prostate cancer (PCa) is the second most commonly diagnosed cancer in men with around
1.4 million new cases every year. In patients with localized disease, management options …